| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 111 |
| 1 | METHOTREXATE SODIUM | 111 |
| 2 | FOLIC ACID | 104 |
| 3 | ETANERCEPT | 103 |
| 4 | LEFLUNOMIDE | 95 |
| 5 | METHOTREXATE | 95 |
| 6 | TOFACITINIB | 95 |
| 7 | SULFASALAZINE | 92 |
| 8 | PREDNISONE | 88 |
| 9 | INFLIXIMAB | 76 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLD | 28 | 0.0048 |
| 1 | SODIUM MONOFLUOROPHOSPHATE | 1 | 0.0027 |
| 2 | GOLIMUMAB | 34 | 0.0027 |
| 3 | DEOXYCHOLIC ACID | 5 | 0.0021 |
| 4 | INDOMETHACIN | 22 | 0.0017 |
| 5 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0015 |
| 6 | SULFASALAZINE | 92 | 0.0012 |
| 7 | DIFLUPREDNATE OPHTHALMIC | 1 | 0.0011 |
| 8 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0011 |
| 9 | TOFACITINIB CITRATE | 14 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 117 |
| 1 | Vitamin C [EPC] | 110 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 108 |
| 3 | Vitamin B12 [EPC] | 104 |
| 4 | Vitamin D [EPC] | 104 |
| 5 | Antirheumatic Agent [EPC] | 95 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 95 |
| 7 | Aminosalicylate [EPC] | 93 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 73 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 70 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytolytic Agent [EPC] | 5 | 0.0021 |
| 1 | Aminosalicylate [EPC] | 93 | 0.0009 |
| 2 | Antirheumatic Agent [EPC] | 95 | 0.0009 |
| 3 | Provitamin D2 Compound [EPC] | 17 | 0.0006 |
| 4 | Interleukin-17A Antagonist [EPC] | 18 | 0.0005 |
| 5 | Bismuth [EPC] | 2 | 0.0004 |
| 6 | Vitamin D [EPC] | 104 | 0.0003 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 48 | 0.0003 |
| 8 | Vitamin B12 [EPC] | 104 | 0.0003 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 42 | 0.0003 |